Inmode ( (INMD) ) has released its Q4 earnings. Here is a breakdown of the information Inmode presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
InMode Ltd., a global leader in innovative medical technologies, focuses on developing, manufacturing, and marketing devices utilizing novel radio frequency technology to enable new surgical procedures and enhance existing treatments across various medical fields.
InMode reported its financial results for the fourth quarter and full year of 2024, highlighting a decline in revenue compared to 2023. The company returned a substantial amount of capital to shareholders through share repurchases and announced a new share buyback program.
The financial performance in 2024 saw a 20% decrease in annual revenue, amounting to $394.8 million, and a notable decline in operating income. Despite this, the company maintained a strong cash position of $596.5 million. InMode’s active share repurchase programs have significantly reduced outstanding shares, enhancing shareholder value.
Looking ahead, InMode is optimistic about its innovative product launches, including the Ignite and OptimasMAX platforms, which are expected to contribute to revenue growth. The company plans to introduce additional platforms targeting the medical aesthetic and wellness markets in 2025.
InMode’s management remains focused on leveraging its strong market position and financial flexibility to navigate current challenges and drive future growth, while continuing to explore opportunities for additional capital returns to shareholders.
